Feedback (LON:FDBK) Trading Down 11.5% – Should You Sell?

Feedback plc (LON:FDBKGet Free Report)’s share price dropped 11.5% during trading on Monday . The company traded as low as GBX 11 and last traded at GBX 11.50. Approximately 80,531 shares traded hands during mid-day trading, a decline of 34% from the average daily volume of 121,994 shares. The stock had previously closed at GBX 13.

Feedback Stock Performance

The company has a fifty day moving average of GBX 9.15 and a two-hundred day moving average of GBX 11.11. The company has a market cap of £5.04 million, a PE ratio of -0.45 and a beta of 0.77.

Insider Activity

In other news, insider Tom Oakley purchased 60,904 shares of the business’s stock in a transaction that occurred on Tuesday, December 23rd. The shares were bought at an average cost of GBX 8 per share, for a total transaction of £4,872.32. Also, insider Emma Oswick (Stuart) bought 60,459 shares of the company’s stock in a transaction on Tuesday, December 23rd. The shares were acquired at an average price of GBX 8 per share, with a total value of £4,836.72. 7.98% of the stock is currently owned by company insiders.

Feedback Company Profile

(Get Free Report)

Feedback plc (AIM: FDBK) provides innovative software and systems through its trading subsidiary, Feedback Medical.

Feedback liberates data and knowledge from multiple healthcare IT systems and delivers better workflows to enable clinicians to communicate, collaborate and provide the best healthcare for their patients. It connects care settings with diagnostic and other relevant data to drive better, faster, safer decision that improve outcomes for patients.

By linking different clinical systems together into a seamless view of the patient, Feedback can streamline patient pathways and deliver a digital health and diagnostics record across multiple care providers.

Bleepa® is a communication and collaboration platform that displays clinical results at a certified and regulated quality, which enables multi-disciplinary team working and diagnostic-enhanced advice and guidance.

Featured Stories

Receive News & Ratings for Feedback Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Feedback and related companies with MarketBeat.com's FREE daily email newsletter.